V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190008817 | 190006930 | 0 | 51.6 | Palliative (P) | 2019-12-26 | 2019-12-31 | NB HRNBL-1 COJEC Ind COURSE C | 02 | N | CISPLATIN + FLUOROURACIL | 101375934 |
| 190008819 | 190006931 | 1.49 | 63 | Neo-adjuvant (N) | 2020-09-26 | 2020-09-28 | ETOPOSIDE | 01 | null | STS NON-RHABDO EPSSG 2005 VINORELBINE | 100543326 |
| 190008834 | 190006932 | 1.72 | 53.9 | Palliative (P) | 2020-02-21 | 2020-03-11 | Dox + HD Mtx (post PAM) | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101678873 |
| 190008845 | 190006933 | 0 | 24.9 | Palliative (P) | 2016-11-20 | 2017-06-09 | PACLITAXEL | 02 | N | CISPLATIN + RT | 100927741 |
| 190008855 | 190006934 | 1.58 | 45.3 | Palliative (P) | 2020-04-04 | 2020-11-20 | Cisplatin + Fluorouracil + RT 5day | 02 | N | ENZALUTAMIDE | 101595057 |
| 190008859 | 190006935 | 0 | 38.9 | null | 2020-04-27 | 2020-08-29 | VAC | 02 | N | GEMCITABINE | 101563739 |
| 190008866 | 190006936 | 0 | 0 | Curative (C) | 2019-05-22 | 2019-05-23 | null | 02 | N | DOCETAXEL | 101097471 |
| 190008891 | 190006937 | 1.74 | 75.6 | Palliative (P) | 2017-03-23 | 2017-10-21 | ABEMACICLIB + FULVESTRANT | 02 | N | BENDAMUSTINE + RITUXIMAB | 101394510 |
| 190008894 | 190006938 | 2.13 | 31.9 | Neo-adjuvant (N) | 2020-08-11 | 2020-11-27 | null | 02 | N | CAPECITABINE + OXALIPLATIN | 100552932 |
| 190008914 | 190006939 | 1.82 | 9.8 | Palliative (P) | 2020-11-02 | 2021-04-04 | Gemcitabine 1000mg/m2 D1 8 15 | N | null | EVEROLIMUS | 100464288 |
| 190008923 | 190006940 | 0 | 30.6 | Disease modification (D) | null | 2021-11-30 | Carboplatin AUC 6 - 10 | null | null | CARBOPLATIN | 101035732 |
| 190008952 | 190006941 | 0 | 55 | null | 2020-08-29 | 2021-03-11 | Cisplatin + Radiotherapy | 02 | null | CISPLATIN | 101825577 |
| 190008969 | 190006942 | 2.13 | 69 | Adjuvant (A) | 2020-12-17 | 2021-06-21 | CARBOPLATIN + PACLITAXEL | N | N | CARBOPLATIN + PACLITAXEL | 101317787 |
| 190008986 | 190006943 | 0 | 42.5 | Neo-adjuvant (N) | 2019-10-29 | 2020-01-25 | EW Rel rEECur Ifosfamide | 02 | N | CARBOPLATIN + PACLITAXEL | 101100381 |
| 190008992 | 190006944 | 1.58 | null | Curative (C) | 2020-01-20 | 2020-03-11 | Topotecan (oral) | 02 | N | AZACITIDINE + VENETOCLAX | 100088471 |
| 190008994 | 190006945 | 1.58 | 36 | null | 2021-11-08 | 2021-11-14 | CARBOPLATIN + PACLITAXEL | null | null | CARBOPLATIN + PACLITAXEL | 101583290 |
| 190009001 | 190006946 | 1.83 | 69.3 | Neo-adjuvant (N) | 2019-11-30 | 2019-12-07 | VAC | 02 | N | TEMOZOLOMIDE | 100546701 |
| 190009011 | 190006947 | 1.8 | 65.2 | null | 2019-01-14 | 2019-08-17 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100810051 |
| 190009022 | 190006948 | null | 62.1 | null | 2022-01-06 | 2022-01-06 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100629178 |
| 190009035 | 190006949 | 1.67 | 52 | null | null | 2016-04-16 | EW EuroEwing 2012 Arm A/B Zol Acid | 02 | null | CARBOPLATIN + ETOPOSIDE | 100827071 |
| 190009044 | 190006950 | 1.46 | 25.8 | Curative (C) | 2017-02-24 | 2017-03-25 | Docetaxel 100mg/m2 (21 day) | 02 | N | BLEOMYCIN + CISPLATIN + ETOPOSIDE + METHOTREXATE + VINCRISTINE | 101825501 |
| 190009051 | 190006951 | 0 | 40 | Adjuvant (A) | 2020-04-05 | 2020-04-14 | Ifosfamide | 02 | null | CISPLATIN + RT | 100985989 |
| 190009057 | 190006952 | 1.59 | 73.5 | Palliative (P) | 2018-10-15 | 2018-11-26 | Cisplatin | 02 | N | CISPLATIN | 100942308 |
| 190009058 | 190006953 | 1.8 | 82.1 | 01 | 2019-03-17 | 2019-10-25 | Capecitabine + Streptozocin | 02 | null | CISPLATIN + PACLITAXEL | 100979612 |
| 190009074 | 190006954 | 1.63 | 53.3 | Curative (C) | 2018-03-25 | 2018-03-25 | EW EuroEwing 2012 Arm A VAC | 01 | N | FLUOROURACIL + OXALIPLATIN | 100895919 |
| 190009075 | 190006955 | 1.79 | 101 | Palliative (P) | 2016-08-07 | 2016-12-27 | CAPECITABINE + TEMOZOLOMIDE | 02 | null | FLUOROURACIL + IRINOTECAN | 100596210 |
| 190009108 | 190006956 | 1.56 | null | Palliative (P) | 2021-03-01 | 2021-03-01 | VAC | 02 | N | CARBOPLATIN + ETOPOSIDE | 101069425 |
| 190009138 | 190006957 | 0 | 115.2 | null | 2019-10-28 | 2020-01-19 | CARBOPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + PACLITAXEL | 02 | null | CISPLATIN + GEMCITABINE | 100191597 |
| 190009152 | 190006958 | 1.68 | 77.7 | Palliative (P) | 2020-05-27 | 2020-12-13 | Cisplatin | 01 | N | CISPLATIN | 100349515 |
| 190009155 | 190006959 | 1.79 | null | Palliative (P) | 2018-02-06 | 2018-02-11 | NB HRNBL-1 Isotretinoin | 02 | N | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 100425885 |
| 190009164 | 190006960 | 1.85 | 93 | Palliative (P) | 2021-02-14 | 2021-02-18 | NB HRNBL-1 COJEC Ind COURSE B | 02 | N | CARBOPLATIN + ETOPOSIDE | 100979202 |
| 190009192 | 190006961 | 1.9 | 49.8 | Neo-adjuvant (N) | null | 2022-05-06 | EW EuroEwing 2012 Arm A VIDE | 02 | null | CABOZANTINIB | 100316469 |
| 190009196 | 190006962 | 1.81 | 48.4 | Palliative (P) | 2022-01-27 | 2022-03-10 | EURAMOS TRIAL | null | null | CAPECITABINE + CARBOPLATIN | 100289747 |
| 190009200 | 190006963 | 0 | 20.4 | Neo-adjuvant (N) | 2019-04-27 | 2019-05-25 | EW EuroEwing 2012 Arm A VAI | Y | Y | FLUOROURACIL + IRINOTECAN | 100160406 |
| 190009215 | 190006964 | null | 67.8 | null | 2018-09-26 | 2019-03-15 | Trial Unspecified | 02 | Y | PACLITAXEL | 100645235 |
| 190009227 | 190006965 | 1.71 | 91.2 | Palliative (P) | 2018-08-03 | 2018-08-19 | NIVOLUMAB | 02 | N | CARBOPLATIN + ETOPOSIDE | 101626008 |
| 190009232 | 190006966 | 1.88 | 45 | Palliative (P) | 2021-02-12 | 2021-02-13 | Doxorubicin + Methotrexate | 02 | Y | CAPECITABINE + CARBOPLATIN | 100547903 |
| 190009242 | 190006967 | 1.6 | 72 | null | 2020-11-19 | 2021-03-30 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100579455 |
| 190009251 | 190006968 | 1.71 | 52.7 | Palliative (P) | 2020-06-18 | 2020-11-30 | Carboplatin AUC 6 - 10 | null | null | CARBOPLATIN | 100686808 |
| 190009262 | 190006969 | 0 | 26.1 | Palliative (P) | 2020-01-06 | 2020-01-29 | STS Non-Rhabdo EpSSG 2005 Ifos | N | N | TRIAL UNSPECIFIED | 100285155 |
| 190009291 | 190006970 | 0 | 34 | Palliative (P) | 2020-11-08 | 2020-11-08 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100709712 |
| 190009322 | 190006971 | 1.7 | 73.9 | Curative (C) | 2018-01-11 | 2018-06-03 | CARBOPLATIN | N | N | NIVOLUMAB | 100420074 |
| 190009326 | 190006972 | null | 71.6 | null | 2017-01-20 | 2017-07-12 | CAPECITABINE + OXALIPLATIN | N | Y | TRIAL UNSPECIFIED | 100858772 |
| 190009329 | 190006973 | 1.59 | 76.8 | Curative (C) | 2019-06-04 | 2019-12-08 | Gemcitabine day 1&8 | Y | N | ECX | 100062057 |
| 190009332 | 190006974 | 0 | 64 | Palliative (P) | 2020-08-04 | 2020-09-02 | Docetaxel + nintedanib | 02 | N | PACLITAXEL | 100433526 |
| 190009340 | 190006975 | 1.81 | 40.2 | Curative (C) | 2021-12-29 | 2021-12-29 | EURAMOS TRIAL | 02 | N | TRIAL UNSPECIFIED | 101125216 |
| 190009351 | 190006976 | 0 | 39.8 | Curative (C) | 2021-06-11 | 2021-06-11 | null | 02 | null | TRABECTEDIN | 100077163 |
| 190009357 | 190006977 | 1.82 | 62.6 | Palliative (P) | 2019-05-14 | 2019-06-29 | FLUOROURACIL + OXALIPLATIN | 02 | null | CAPECITABINE | 101866940 |
| 190009359 | 190006978 | 1.45 | 56.9 | Curative (C) | null | 2021-12-03 | EW EuroEwing 2012 Arm A VAC | 01 | N | GEMCITABINE | 100505515 |
| 190009362 | 190006979 | 1.56 | 59 | Palliative (P) | 2019-06-12 | 2019-07-09 | Cisplatin + Radiotherapy | N | N | CISPLATIN | 101698984 |